EU approves SPR's nerve stimulation device for chronic shoulder pain

01/25/2013 | MedGadget.com

SPR Therapeutics has obtained CE mark approval to market its Smartpatch Peripheral Nerve Stimulation device in Europe. The technology, which can be used for a maximum of 30 days, uses peripheral nerve stimulation to treat chronic shoulder pain. The company also is pursuing FDA approval for use of the device in treating post-amputation and post-stroke pain.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA